Randomised control study evaluating the efficacy and intestinal microbiota by perioperative administration of probiotics for liver transplant recipients

Randomised control study evaluating the efficacy and intestinal microbiota by perioperative administration of probiotics for liver transplant recipients - Probiotics for liver transplant recipients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220249

Enrollment

Registered

2016-05-20

Start date

2016-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver transplant recipient

Interventions

Intervention type:DRUG Name of intervention:Probiotics for liver transplant recipients Dose form / Japanese Medical Device Nomenclature:TABLET Route of administration / Site of application:ORAL,ENTERA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Liver transplant recipiets >= 20 years old Eligible for enteral feeding Written informed consent

Exclusion criteria

Exclusion criteria: Who has a history of allergy to the drug Those whom attending doctors regarded as inappropriate as candidates

Design outcomes

Primary

Measure	Time frame
Laboratory test results including blood examination and microbiological examination Vital signs surgical complications including infection, rejection, prognosis	—

Countries

Japan

Contacts

Public ContactMiki Nagao

Kyoto University Hospital

ict@kuhp.kyoto-u.ac.jp+81-75-751-4967

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026